The Biolabels Development Unit focuses on developing nanomaterials-based systems for applications in Therapeutics and Diagnostics.
To become a leading innovator in the field of nanomedicine and to develop expertise in the field of nanomedicine or nanotechnology in South Africa.
To develop nanomaterials-based systems for applications in Therapeutics and Diagnostics to address the socio-economic problems of Africa.
To develop functionalised metal nanoparticles (or tools) for in-vivo imaging and therapeutic applications and to design and develop nanotechnology-based point-of-care (POC) diagnostics.
This platform focuses on research and development of functionalised metal nanoparticle systems for therapeutics and targeted drug delivery.
The diagnostic platform focuses on the design and development of rapid diagnostic tests for human and animal diseases and labelling reagents for in vivo imaging.
Testing of nanomaterial toxicity on various cell lines for first line exposure assessment and drug efficacy.
The production of peptides and peptoids for use in medical device fabrication and cosmetics.
Various equipment and infrastructure available for production and testing.
Meet the NIC Biolabels Team headed by Dr. Amanda Skepu.